Hostname: page-component-586b7cd67f-r5fsc Total loading time: 0 Render date: 2024-11-24T09:15:57.625Z Has data issue: false hasContentIssue false
  • English
  • Français

Investigation of myocardial dysfunction using three-dimensional speckle tracking echocardiography in a genetic positive hypertrophic cardiomyopathy Chinese family

Published online by Cambridge University Press:  06 July 2018

Jing Wang ,
Rui-Qi Guo ,
Jian-Ying Guo ,
Lei Zuo ,
Chang-Hui Lei ,
Hong Shao ,
Li-Feng Wang ,
Yan-Min Zhang  and
Li-Wen Liu
Jing Wang
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Rui-Qi Guo
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Jian-Ying Guo
Affiliation:
Military Patients Reception Center, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Lei Zuo
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Chang-Hui Lei
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Hong Shao
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China Department of Cardiology, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
Li-Feng Wang
Affiliation:
Department of Biochemistry and Molecular Biology, Fourth Military Medical University, Xi’an, Shaanxi, China
Yan-Min Zhang
Affiliation:
Xi’an Children’s Hospital of Xi’an Jiaotong University, Children’s Research Institute of Shaanxi Province, Xi’an, Shaanxi, China
Li-Wen Liu*
Affiliation:
Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi, China
*
Author for correspondence: Prof. L.-W. Liu, Department of Ultrasound, Xijing Hospital, Fourth Military Medical University, Xi’an, Shaanxi 710032, China. Tel: +86 29 8477 5443; Fax: +86 29 8324 4121; E-mail: [email protected]
Get access Rights & Permissions [Opens in a new window]

Abstract

Background

We previously reported four heterozygous missense mutations of MYH7, KCNQ1, MYLK2, and TMEM70 in a single three-generation Chinese family with dual Long QT and hypertrophic cardiomyopathy phenotypes for the first time. However, the clinical course among the family members was various, and the potential myocardial dysfunction has not been investigated.

Objectives

The objective of this study was to investigate the echocardiographic and electrocardiographic characteristics in a genetic positive Chinese family with hypertrophic cardiomyopathy and further to explore the association between myocardial dysfunction and electric activity, and the identified mutations.

Methods

A comprehensive echocardiogram – standard two-dimensional Doppler echocardiography and three-dimensional speckle tracking echocardiography – and electrocardiogram were obtained for members in this family.

Results

As previously reported, four missense mutations – MYH7-H1717Q, KCNQ1-R190W, MYLK2-K324E, and TMEM70-I147T – were identified in this family. The MYH7-H1717Q mutation carriers had significantly increased left ventricular mass indices, elevated E/e’ ratio, deteriorated global longitudinal stain, but enhanced global circumferential and radial strain compared with those in non-mutation patients (all p<0.05). The KCNQ1-R190W carriers showed significantly prolonged QTc intervals, and the MYLK2-K324E mutation carriers showed inverted T-waves (both p<0.05). However, the TMEM70-I147T mutation carriers had similar echocardiography and electrocardiographic data as non-mutation patients.

Conclusions

Three of the identified four mutations had potential pathogenic effects in this family: MYH7-H1717Q was associated with increased left ventricular thickness, elevated left ventricular filling pressure, and altered myocardial deformation; KCNQ1-R190W and MYLK2-K324E mutations were correlated with electrocardiographic abnormalities reflected in long QT phenotype and inverted T-waves, respectively.

Keywords

Hypertrophic cardiomyopathymyocardial dysfunctionthree-dimensional speckle tracking echocardiographymultiple mutations
Type
Original Article
Information
Cardiology in the Young , Volume 28 , Issue 9 , September 2018 , pp. 1106 - 1114
Check for updates
Copyright
© Cambridge University Press 2018 

Access options

Get access to the full version of this content by using one of the access options below. (Log in options will check for institutional or personal access. Content may require purchase if you do not have access.)

Footnotes

Cite this article: Wang J, Guo R-Q, Guo J-Y, Zuo L, Lei C-H, Shao H, Wang L-F, Zhang Y-M, Liu L-W. (2018). Investigation of myocardial dysfunction using three-dimensional speckle tracking echocardiography in a genetic positive hypertrophic cardiomyopathy Chinese family. Cardiology in the Young28: 1106–1114. doi: 10.1017/S1047951118000860

*

Jing Wang, Rui-Qi Guo, and Jian-Ying Guo contributed equally to this work.

References

1. Maron, BJ. Hypertrophic cardiomyopathy: a systematic review. JAMA 2002; 287: 1308–1320.Google Scholar
2. Bos, JM, Towbin, JA, Ackerman, MJ. Diagnostic, prognostic, and therapeutic implications of genetic testing for hypertrophic cardiomyopathy. J Am Coll Cardiol 2009; 54: 201–211.Google Scholar
3. Ho, CY. Genetics and clinical destiny: improving care in hypertrophic cardiomyopathy. Circulation 2010; 122: 2430–2440.Google Scholar
4. McLeod, CJ, Bos, JM, Theis, JL, et al. Histologic characterization of hypertrophic cardiomyopathy with and without myofilament mutations. Am Heart J 2009; 158: 799–805.Google Scholar
5. Marian, AJ. Pathogenesis of diverse clinical and pathological phenotypes in hypertrophic cardiomyopathy. Lancet 2000; 355: 58–60.Google Scholar
6. Ackerman, MJ, Priori, SG, Willems, S, et al. HRS/EHRA expert consensus statement on the state of genetic testing for the channelopathies and cardiomyopathies: this document was developed as a partnership between the Heart Rhythm Society (HRS) and the European Heart Rhythm Association (EHRA). Europace 2011; 13: 1077–1109.Google Scholar
7. Authors/Task Force members, Elliott PM, Anastasakis A, et al. 2014 ESC Guidelines on diagnosis and management of hypertrophic cardiomyopathy: the Task Force for the Diagnosis and Management of Hypertrophic Cardiomyopathy of the European Society of Cardiology (ESC). Eur Heart J, 2014; 35: 2733-2779.CrossRefGoogle Scholar
8. Wang, L, Zuo, L, Hu, J, et al. Dual LQT1 and HCM phenotypes associated with tetrad heterozygous mutations in KCNQ1, MYH7, MYLK2, and TMEM70 genes in a three-generation Chinese family. Europace 2016; 18: 602–609.Google Scholar
9. Lang, RM, Badano, LP, Mor-Avi, V, et al. Recommendations for cardiac chamber quantification by echocardiography in adults: an update from the American Society of Echocardiography and the European Association of Cardiovascular Imaging. J Am Soc Echocardiogr 2015; 28: 1–39.e14.CrossRefGoogle ScholarPubMed
10. Nagueh, SF, Appleton, CP, Gillebert, TC, et al. Recommendations for the evaluation of left ventricular diastolic function by echocardiography. J Am Soc Echocardiogr 2009; 22: 107–133.Google Scholar
11. Diodato, D, Invernizzi, F, Lamantea, E, et al. Common and novel TMEM70 mutations in a cohort of Italian patients with mitochondrial encephalocardiomyopathy. JIMD Rep 2015; 15: 71–78.Google Scholar
12. Atay, Z, Bereket, A, Turan, S, et al. A novel homozygous TMEM70 mutation results in congenital cataract and neonatal mitochondrial encephalocardiomyopathy. Gene 2013; 515: 197–199.Google Scholar
13. Núñez, L, Gimeno-Blanes, JR, Rodríguez-García, MI, et al. Somatic MYH7, MYBPC3, TPM1, TNNT2, and TNNI3 mutations in sporadic hypertrophic cardiomyopathy. Circ J 2013; 77: 2358–2365.Google Scholar
14. Barsheshet, A, Goldenberg, I, O-Uchi, J, et al. Mutations in cytoplasmic loops of the KCNQ1 channel and the risk of life-threatening events: implications for mutation-specific response to β-blocker therapy in type 1 long-QT syndrome. Circulation 2012; 125: 1988–1996.Google Scholar
15. Davis, JS, Hassanzadeh, S, Winitsky, S, et al. The overall pattern of cardiac contraction depends on a spatial gradient of myosin regulatory light chain phosphorylation. Cell 2001; 107: 631–641.Google Scholar
16. Carasso, S, Yang, H, Woo, A, et al. Systolic myocardial mechanics in hypertrophic cardiomyopathy: novel concepts and implications for clinical status. J Am Soc Echocardiogr 2008; 21: 675–683.Google Scholar
17. Kleijn, SA, Brouwer, WP, Aly, MF, et al. Comparison between three-dimensional speckle-tracking echocardiography and cardiac magnetic resonance imaging for quantification of left ventricular volumes and function. Eur Heart J Cardiovasc Imaging 2012; 13: 834–839.CrossRefGoogle ScholarPubMed
18. Seo, Y, Ishizu, T, Enomoto, Y, et al. Validation of 3-dimensional speckle tracking imaging to quantify regional myocardial deformation. Circ Cardiovasc Imaging 2009; 2: 451–459.CrossRefGoogle ScholarPubMed
19. Kansal, MM, Lester, SJ, Surapaneni, P, et al. Usefulness of two-dimensional and speckle tracking echocardiography in “Gray Zone” left ventricular hypertrophy to differentiate professional football player’s heart from hypertrophic cardiomyopathy. Am J Cardiol 2011; 108: 1322–1326.Google Scholar
20. Baccouche, H, Maunz, M, Beck, T, et al. Differentiating cardiac amyloidosis and hypertrophic cardiomyopathy by use of three-dimensional speckle tracking echocardiography. Echocardiography 2012; 29: 668–677.Google Scholar
21. Wang, TT, Kwon, HS, Dai, G, et al. Resolving myoarchitectural disarray in the mouse ventricular wall with diffusion spectrum magnetic resonance imaging. Ann Biomed Eng 2010; 38: 2841–2850.Google Scholar
22. Urbano-Moral, JA, Rowin, EJ, Maron, MS, et al. Investigation of global and regional myocardial mechanics with 3-dimensional speckle tracking echocardiography and relations to hypertrophy and fibrosis in hypertrophic cardiomyopathy. Circ Cardiovasc Imaging 2014; 7: 11–19.Google Scholar
23. Bing, W, Knott, A, Redwood, C, et al. Effect of hypertrophic cardiomyopathy mutations in human cardiac muscle alpha-tropomyosin (Asp175Asn and Glu180Gly) on the regulatory properties of human cardiac troponin determined by in vitro motility assay. J Mol Cell Cardiol 2000; 32: 1489–1498.Google Scholar
Supplementary material: File

Wang et al. supplementary material

Table S1

Download Wang et al. supplementary material(File)
File 35.2 KB
Supplementary material: File

Wang et al. supplementary material

Table S2

Download Wang et al. supplementary material(File)
File 35.3 KB
Supplementary material: File

Wang et al. supplementary material

Table S3

Download Wang et al. supplementary material(File)
File 34.9 KB